Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD)

Clinical Endocrinology

Volumn 69, Issue 6, 2008, Pages 901-905

  Sommer, Grit ^b   Ziegelmeier, Michaela ^b   Bachmann, Anette ^b   Kralisch, Susan ^b,c   Lossner, Ulrike ^b   Kratzsch, Jürgen ^b   Blüher, Matthias ^b   Stumvoll, Michael ^b   Fasshauer, Mathias ^a,b,c  

^a University of Leipzig ^*  (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE FATTY ACID BINDING PROTEIN; FATTY ACID; FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION; GLUCOSE METABOLISM; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOCYTES; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS;

EID: 55949106095     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03277.x     Document Type: Article

References (28)

1. Fasshauer, M. Paschke, R. (2003) Regulation of adipocytokines and insulin resistance. Diabetologia, 46, 1594 1603.
2. Trujillo, M.E. Scherer, P.E. (2006) Adipose tissue-derived factors: impact on health and disease. Endocrine Reviews, 27, 762 778.
3. Fasshauer, M., Paschke, R. Stumvoll, M. (2004) Adiponectin, obesity, and cardiovascular disease. Biochimie, 86, 779 784.
4. Kralisch, S., Sommer, G., Deckert, C.M., Linke, A., Bluher, M., Stumvoll, M. Fasshauer, M. (2007) Adipokines in diabetes and cardiovascular diseases. Minerva Endocrinology, 32, 161 171.
5. Schafer, K., Halle, M., Goeschen, C., Dellas, C., Pynn, M., Loskutoff, D.J. Konstantinides, S. (2004) Leptin promotes vascular remodeling and neointimal growth in mice. Arteriosclerosis Thrombosis Vascular Biology, 24, 112 117.
6. Xu, A., Wang, Y., Xu, J.Y., Stejskal, D., Tam, S., Zhang, J., Wat, N.M., Wong, W.K. Lam, K.S. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clinical Chemistry, 52, 405 413.
7. Xu, A., Tso, A.W., Cheung, B.M., Wang, Y., Wat, N.M., Fong, C.H., Yeung, D.C., Janus, E.D., Sham, P.C. Lam, K.S. (2007) Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation, 115, 1537 1543.
8. Tso, A.W., Xu, A., Sham, P.C., Wat, N.M., Wang, Y., Fong, C.H., Cheung, B.M., Janus, E.D. Lam, K.S. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care, 30, 2667 2672.
9. Yeung, D.C., Xu, A., Cheung, C.W., Wat, N.M., Yau, M.H., Fong, C.H., Chau, M.T. Lam, K.S. (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arteriosclerosis Thrombosis Vascular Biology, 27, 1796 1802.
10. Veerkamp, J.H. Maatman, R.G. (1995) Cytoplasmic fatty acid-binding proteins: their structure and genes. Progress in Lipid Research, 34, 17 52.
11. Reese-Wagoner, A., Thompson, J. Banaszak, L. (1999) Structural properties of the adipocyte lipid binding protein. BBA Biochemica ET Biophysica Acta, 1441, 106 116.
12. Pelsers, M.M., Hermens, W.T. Glatz, J.F. (2005) Fatty acid-binding proteins as plasma markers of tissue injury. Clinica Chimica Acta, 352, 15 35.
13. Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F.A., Cutrupi, S., Parlongo, S., Malatino, L.S., Bonanno, G., Seminara, G., Rapisarda, F., Fatuzzo, P., Buemi, M., Nicocia, G., Tanaka, S., Ouchi, N., Kihara, S., Funahashi, T. Matsuzawa, Y. (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology, 13, 134 141.
14. Merabet, E., Dagogo-Jack, S., Coyne, D.W., Klein, S., Santiago, J.V., Hmiel, S.P. Landt, M. (1997) Increased plasma leptin concentration in end-stage renal disease. Journal of Clinical Endocrinology Metabolism, 82, 847 850.
15. Ziegelmeier, M., Bachmann, A., Seeger, J., Lossner, U., Kratzsch, J., Bluher, M., Stumvoll, M. Fasshauer, M. (2007) Serum levels of the adipokine RBP-4 in relation to renal function. Diabetes Care, 30, 2588 2592.
16. Seeger, J., Ziegelmeier, M., Bachmann, A., Lossner, U., Kratzsch, J., Bluher, M., Stumvoll, M. Fasshauer, M. (2008) Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. Journal of Clinical Endocrinology Metabolism, 93, 247 251.
17. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412 419.
18. Kratzsch, J., Berthold, A., Lammert, A., Reuter, W., Keller, E. Kiess, W. (2002) A rapid, quantitative immunofunctional assay for measuring human leptin. Hormone Research, 57, 127 132.
19. Hotamisligil, G.S., Johnson, R.S., Distel, R.J., Ellis, R., Papaioannou, V.E. Spiegelman, B.M. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science, 274, 1377 1379.
20. Uysal, K.T., Scheja, L., Wiesbrock, S.M., Bonner-Weir, S. Hotamisligil, G.S. (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology, 141, 3388 3396.
21. Boord, J.B., Maeda, K., Makowski, L., Babaev, V.R., Fazio, S., Linton, M.F. Hotamisligil, G.S. (2002) Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arteriosclerosis Thrombosis Vascular Biology, 22, 1686 1691.
22. Makowski, L., Boord, J.B., Maeda, K., Babaev, V.R., Uysal, K.T., Morgan, M.A., Parker, R.A., Suttles, J., Fazio, S., Hotamisligil, G.S. Linton, M.F. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Medicine, 7, 699 705.
23. Furuhashi, M., Tuncman, G., Gorgun, C.Z., Makowski, L., Atsumi, G., Vaillancourt, E., Kono, K., Babaev, V.R., Fazio, S., Linton, M.F., Sulsky, R., Robl, J.A., Parker, R.A. Hotamisligil, G.S. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature, 447, 959 965.
24. Tuncman, G., Erbay, E., Hom, X., De Vivo, I., Campos, H., Rimm, E.B. Hotamisligil, G.S. (2006) A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proceedings of the National Academy of Sciences of USA, 103, 6970 6975.
25. Stejskal, D. Karpisek, M. (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? European Journal of Clinical Investigations, 36, 621 625.
26. Haider, D.G., Schindler, K., Bohdjalian, A., Prager, G., Luger, A., Wolzt, M. Ludvik, B. (2007) Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes, Obesity and Metabolism, 9, 761 763.
27. Möhlig, M., Weickert, M.O., Ghadamgadai, E., Machlitt, A., Pfuller, B., Arafat, A.M., Pfeiffer, A.F. Schofl, C. (2007) Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. European Journal of Endocrinology, 157, 195 200.
28. Reinehr, T., Stoffel-Wagner, B. Roth, C.L. (2007) Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metabolism, 56, 1735 1741.